Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Fujifilm Showcases DRI-CHEM NX700 Dry Chemistry Analyzer

By LabMedica International staff writers
Posted on 07 Feb 2018
Fujifilm Corporation (Tokyo, Japan) showcased its new generation dry chemistry analyzer series, DRI-CHEM NX700, which can perform multiple test parameters of clinical chemistry, at MEDLAB Middle East 2018.
 
Fujifilm is a pioneer in diagnostic imaging and information systems for healthcare facilities and also provides Point-of-Care Testing products for healthcare providers who need immediate clinical test results. More...
At MEDLAB Middle East 2018, the world’s largest attended laboratory & IVD exhibition and conference held in Dubai, UAE from February 5-8, 2018, Fujifilm showcased its DRI-CHEM NX700 dry chemistry analyzer series which offers a high processing speed of 190 tests per hour and makes it possible to set five samples at the same time.
 
Equipped with STAT functionality to accommodate emergency interrupt measurement, the DRI-CHEM NX700 does not require pre-treatment of sample or calibration using the QC card system. It offers easy operations with a touch screen and intuitive new software, along with enhanced connectivity features and HL7 support. The DRI-CHEM NX700 dry chemistry analyzer series is patient-friendly as it requires a testing microsample of only 6 μL and 10 μL per test. Featuring a new design with a compact size and smaller foot print, it allows for the use of different range of sample tubes.
 

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Clinical Chemistry System
P780
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.